Virus kinetics and biochemical derangements among children with Ebolavirus disease

Autor: Lindsey Kjaldgaard, Kasereka Masumbuko Claude, Daniel Mukadi-Bamuleka, Richard Kitenge-Omasumbu, Devika Dixit, François Edidi-Atani, Meris Matondo Kuamfumu, Junior Bulabula-Penge, Fabrice Mambu-Mbika, Olivier Tshiani-Mbaya, Janet Diaz, Sabue Mulangu, Anais Legand, Placide Mbala-Kingebeni, Pierre Formenty, Steve Ahuka-Mundeke, Jean-Jacques Muyembe-Tamfum, Michael T. Hawkes

Publikováno v: EClinicalMedicine, Vol 53, Iss , Pp 101638- (2022)

Summary: Background: A paucity of data is available on virologic and biochemical characteristics of paediatric Ebolavirus disease (EVD), compared to adults. Methods: We conducted a retrospective chart review of children (7.6 log10copies/mL, alanine t

Externí odkaz: https://doaj.org/article/cac8e90131de4e13ba663a81f3fec770

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine

Autor: Francesco Santoro, Alessia Donato, Simone Lucchesi, Sara Sorgi, Alice Gerlini, Marielle C. Haks, Tom H. M. Ottenhoff, Patricia Gonzalez-Dias, VSV-EBOVAC Consortium, VSV-EBOPLUS Consortium, Helder I. Nakaya, Angela Huttner, Claire-Anne Siegrist, Donata Medaglini, Gianni Pozzi

Publikováno v: Vaccines, Vol 9, Iss 2, p 67 (2021)

Ebolavirus Disease (EVD) is a severe haemorrhagic fever that occurs in epidemic outbreaks, with a high fatality rate and no specific therapies available. rVSVΔG-ZEBOV-GP (Ervebo®), a live-attenuated recombinant vesicular stomatitis virus vector exp

Externí odkaz: https://doaj.org/article/0cc37b3556264c92acdea5514faf43ff

Human Transcriptomic Response to the VSV-Vectored Ebola Vaccine

Autor: Alessia Donato, Mariëlle C. Haks, Simone Lucchesi, Helder I. Nakaya, Angela Huttner, Patrícia Gonzalez-Dias, Gianni Pozzi, Donata Medaglini, Francesco Santoro, Alice Gerlini, Tom H. M. Ottenhoff, Sara Sorgi, Claire-Anne Siegrist

Publikováno v: Vaccines, Vol 9, Iss 67, p 67 (2021)
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Vaccines
Vaccines, 9(2). MDPI
Volume 9
Issue 2

Ebolavirus Disease (EVD) is a severe haemorrhagic fever that occurs in epidemic outbreaks, with a high fatality rate and no specific therapies available. rVSVΔG-ZEBOV-GP (Ervebo®), a live-attenuated recombinant vesicular stomatitis virus vector exp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff9dd29cd87fe1927a453bbd9dc3d4d1
https://www.mdpi.com/2076-393X/9/2/67

Epidemiology of ebolavirus disease (EVD) and occupational EVD in health care workers in Sub-Saharan Africa: Need for strengthened public health preparedness

Autor: Sayumi Nojima, Ndona Madone-Mandina, Mabasi Godefroid-Mayala, Joa Okech-Ojony, Ntumba Jean-Marie Kayembe, Mukunda Gaspard-Kibukusa, Lubogo Mutaawe, Masika Patou-Musumari, Elayne Kornblatt Phillips, Nlandu Roger Ngatu, Dimosi Roger-Wumba, Casimir Manzengo

Publikováno v: Journal of Epidemiology, Vol 27, Iss 10, Pp 455-461 (2017)
Journal of Epidemiology

Ebolavirus disease (EVD) is a severe contagious disease in humans, and health care workers (HCW) are at risk of infection when caring for EVD patients. This paper highlights the epidemiologic profile of EVD and its impact on the health care workforce

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8883de6dca899dc081880e3532a98d76
https://doi.org/10.1016/j.je.2016.09.010

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.